Association between quality metric adherence and overall survival among patients undergoing resection of pancreatic ductal adenocarcinoma

被引:0
|
作者
Munir, Muhammad Musaab [1 ]
Rashid, Zayed [1 ]
Endo, Yutaka [1 ]
Dillhoff, Mary [1 ]
Tsai, Susan [1 ]
Pawlik, Timothy M. [1 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Dept Surg, 395 W 12th Ave,Suite 670, Columbus, OH 43210 USA
关键词
LENGTH-OF-STAY; CANCER CARE; PANCREATICODUODENECTOMY;
D O I
10.1016/j.surg.2024.04.043
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Process-based quality metrics are important for improving long-term outcomes after surgical resection. We sought to develop a practical surgical quality score for patients diagnosed with pancreatic ductal adenocarcinoma undergoing curative-intent resection. Methods: Patients who underwent surgical resection for pancreatic ductal adenocarcinoma between 2010 and 2017 were identified using the National Cancer Database. Five surgical quality metrics were defined: minimally invasive approach, adequate lymphadenectomy, negative surgical margins, receipt of adjuvant therapy, and no prolonged hospitalization. Log-rank test and multivariable Cox regression analysis were used to determine the association of quality metrics with overall survival. Results: A total of 38,228 patients underwent curative-intent resection for pancreatic ductal adenocarcinoma. Median age at diagnosis was 68 years (interquartile range = 61-75), and roughly half the cohort was male (n = 19,562; 51.2%). Quality metrics were achieved on a varied basis: minimally invasive approach (n = 5,701; 14.9%), adequate lymphadenectomy (n = 27,122; 80.0%), negative surgical margin (n = 29,248; 76.5%), receipt of adjuvant therapy (n = 26,006; 68.0%), and absence of prolonged hospitalization (n = 26,470; 69.2%). An integer-based surgical quality score from 0 (no quality metrics) to 16 (all quality metrics) was calculated. Patients with higher scores had progressively better overall survival. Median overall survival differed substantially among the score categories (score = 0-4 points, 8.7 [8.0-9.6] months; 5-8 points, 17.5 [16.9-18.2] months; 9-12 points, 22.1 [21.6-22.8] months; and 13-16 points, 30.8 [30.2-31.3] months; P < .001). On multivariable analysis, risk-adjusted mortality hazards decreased in a stepwise manner with higher scores (0-4 points: reference; 5-8 points: multivariable adjusted hazard ratio = 0.60; 95% CI, 0.57-0.63; 9-12 points: adjusted hazard ratio = 0.49; 95% CI, 0.47-0.52; 13-16 points: and adjusted hazard ratio = 0.37; 95% CI, 0.34-0.40; all P < .001). Conclusion: Adherence to quality metrics may be associated with improved overall survival. Efforts aimed at increasing compliance with quality metric measures may help optimize long-term outcomes among patients undergoing surgical resection for pancreatic ductal adenocarcinoma. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:873 / 879
页数:7
相关论文
共 50 条
  • [1] Statins potentially improve survival of patients undergoing curative resection for pancreatic ductal adenocarcinoma
    Petermann, D.
    Kefleyesus, A.
    Demartines, N.
    Schaefer, M.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 6 - 7
  • [2] The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection
    Elisabeth S. Gruber
    Gerd Jomrich
    Alexandra Kaider
    Michael Gnant
    Klaus Sahora
    Martin Schindl
    Annals of Surgical Oncology, 2020, 27 : 2017 - 2024
  • [3] The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection
    Gruber, Elisabeth S.
    Jomrich, Gerd
    Kaider, Alexandra
    Gnant, Michael
    Sahora, Klaus
    Schindl, Martin
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (06) : 2017 - 2024
  • [4] Sarcopenic Obesity in Patients Undergoing Pancreatic Ductal Adenocarcinoma Resection
    Wienerroither, Valerie
    Wagner, Doris
    Schemmer, Peter
    Mischinger, Hans J.
    Kornprat, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S153 - S154
  • [5] How does additional venous resection impact the overall survival of patients undergoing resection for pancreatic adenocarcinoma?
    McGurk, Catherine
    BRITISH JOURNAL OF SURGERY, 2020, 107 : 56 - 56
  • [6] Correction to: The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection
    Elisabeth S. Gruber
    Gerd Jomrich
    Alexandra Kaider
    Michael Gnant
    Klaus Sahora
    Martin Schindl
    Annals of Surgical Oncology, 2020, 27 : 985 - 985
  • [7] Comments: The Prognostic Index Independently Predicts Survival in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Resection
    Qiqing Sun
    Yiyin Zhang
    Xiaowu Xu
    Annals of Surgical Oncology, 2020, 27 : 944 - 945
  • [8] Comments: The Prognostic Index Independently Predicts Survival in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Resection
    Sun, Qiqing
    Zhang, Yiyin
    Xu, Xiaowu
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (Suppl 3) : 944 - 945
  • [9] Prognostic impact of osteosarcopenia in patients undergoing pancreatic resection for pancreatic ductal adenocarcinoma
    Yanagaki, Mitsuru
    Onda, Shinji
    Gocho, Takeshi
    Igarashi, Yosuke
    Shirai, Yoshihiro
    Okui, Norimitsu
    Matsumoto, Michinori
    Sakamoto, Taro
    Haruki, Koichiro
    Ikegami, Toru
    LANGENBECKS ARCHIVES OF SURGERY, 2024, 409 (01)
  • [10] Correlation Between Antihypertensive Drugs and Survival Among Patients with Pancreatic Ductal Adenocarcinoma
    Kluz, Natalia
    Kraj, Leszek
    Chmiel, Paulina
    Przybylkowski, Adam M.
    Wyrwicz, Lucjan
    Stec, Rafal
    Szymanski, Lukasz
    CANCERS, 2024, 16 (23)